Consensus validation study establishes tiered diagnostic criteria for progressive supranuclear palsy, highlighting distinct categories optimized for clinical trials and epidemiology.
Key Points
To establish and validate standardized, universally accepted clinical research criteria with enhanced sensitivity and specificity for progressive supranuclear palsy.
Convened an international expert workshop sponsored by NINDS and SPSP to synthesize literature and compare existing diagnostic systems.
Validated the consensus diagnostic criteria against clinical records from autopsy-confirmed cases of progressive supranuclear palsy.
Established three diagnostic tiers (possible, probable, and definite) requiring onset at age 40 or older, vertical supranuclear gaze palsy, slow vertical saccades, and early postural instability with falls.
Demonstrated that probable criteria yield high specificity optimal for therapeutic and analytical studies, whereas possible criteria offer broad sensitivity suitable for descriptive epidemiologic surveys.